Morphine treatment accelerates sarcoma-induced bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer
about
A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone lossUse of Animal Models in Understanding Cancer-induced Bone PainBehavioral, medical imaging and histopathological features of a new rat model of bone cancer painImaging opioid analgesia in the human brain and its potential relevance for understanding opioid use in chronic pain.Dissociation between the relief of skeletal pain behaviors and skin hypersensitivity in a model of bone cancer pain.The role of alpha 6 integrin in prostate cancer migration and bone pain in a novel xenograft modelNeuron-restrictive silencer factor-mediated downregulation of μ-opioid receptor contributes to the reduced morphine analgesia in bone cancer pain.Suppression of asparaginyl endopeptidase attenuates breast cancer-induced bone pain through inhibition of neurotrophin receptors.NADPH-oxidase 2 activation promotes opioid-induced antinociceptive tolerance in mice.Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer pain.Counter-regulation of opioid analgesia by glial-derived bioactive sphingolipids.Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain.New advances in musculoskeletal pain.Effects of different electroacupuncture scheduling regimens on murine bone tumor-induced hyperalgesia: sex differences and role of inflammation.Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists.Spinal mitochondrial-derived peroxynitrite enhances neuroimmune activation during morphine hyperalgesia and antinociceptive tolerance.Impacts of anti-nerve growth factor antibody on pain-related behaviors and expressions of opioid receptor in spinal dorsal horn and dorsal root ganglia of rats with cancer-induced bone pain.Animal models of cancer pain.Analgesic effects of adenylyl cyclase inhibitor NB001 on bone cancer pain in a mouse model.Postoperative opioid administration inhibits bone healing in an animal model.Spinal activation of delta opioid receptors alleviates cancer-related bone pain.Capsaicin-sensitive sensory nerve fibers contribute to the generation and maintenance of skeletal fracture pain.Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain.Transient receptor potential vanilloid 1-immunoreactive innervation increases in fractured rat femur.Opioid receptor agonists may favorably affect bone mechanical properties in rats with estrogen deficiency-induced osteoporosis.Can regional anesthesia and analgesia prolong cancer survival after orthopaedic oncologic surgery?Chronic Osteoporotic Pain in Mice: Cutaneous and Deep Musculoskeletal Pain Are Partially Independent of Bone Resorption and Differentially Sensitive to Pharmacological Interventions.Effects of miR-338 on morphine tolerance by targeting CXCR4 in a rat model of bone cancer pain.The role of morphine in regulation of cancer cell growth.Bone Pain and Muscle Weakness in Cancer Patients.Synergistic combinations of the dual enkephalinase inhibitor PL265 given orally with various analgesic compounds acting on different targets, in a murine model of cancer-induced bone pain.Mediation of Movement-Induced Breakthrough Cancer Pain by IB4-Binding Nociceptors in Rats.Palliative embolisation for advanced bone sarcomas.Combined micro CT and histopathology for evaluation of skeletal metastasis in live animals.Antagonism of the Met5-enkephalin-opioid growth factor receptor-signaling axis promotes MSC to differentiate into osteoblasts.Chronic morphine administration enhances nociceptive sensitivity and local cytokine production after incisionPotentiation of acute morphine-induced analgesia measured by a thermal test in bone cancer-bearing mice.To Treat or Not to Treat: The Effects of Pain on Experimental Parameters.Disease modifying actions of interleukin-6 blockade in a rat model of bone cancer pain.Involvement of adrenomedullin in spinal glial activation following chronic administration of morphine in rats.
P2860
Q24615787-845477A9-23C8-4571-B1F1-D94ACF023097Q26785501-331ECB08-A643-40D0-96EF-4A12420D6EABQ27317157-43AE17E3-4D2D-453B-A97E-63C9A33794A2Q30657653-302EB638-D5C2-4ADE-A750-FFE936E332ECQ30831131-D9E3786C-4EF7-4395-AB2B-45D4E66D2AD4Q33380192-21C154D0-D047-4769-8752-6B78A2A798F0Q33595867-ED2AC23E-EF24-4A62-AD35-6457142A7DAFQ33752135-69BDB763-62E2-4F8C-864B-B905E5C4721EQ34285878-ABAD2F5F-E487-41C9-AB56-9F644B180398Q34356398-06289FE2-F65C-4DD2-A748-466863EE4AE0Q34399068-23CBC662-59DA-4C68-8E0B-8A4E6D043156Q35540734-6C195143-2244-43D9-AC83-99F20EE064D3Q35701568-CB1108E8-E576-4BF4-AC95-98C3BC86E2E8Q36522438-1CC9A8ED-63E2-4202-B344-9C647791B363Q36558056-8272E4B6-A5E6-4EDC-A5B4-7C57364A051FQ36920496-10E9B786-3D36-416F-B1E4-D6ADA331D7F1Q37114759-C05B3341-A301-4996-B80F-5253DA7F7566Q37203216-BCA9369A-FFDE-4756-81F7-813C17C0C5A7Q37248918-14791319-D4EB-4E09-B694-0196526279D9Q37303297-B91C380A-9992-40D1-81A8-92C05971BAEDQ37360319-3C26C222-AF96-439E-895A-5EE22F6DC3C6Q37398720-0E1454E9-BCD4-42D1-9E73-B90B3441FA0AQ37413252-4CB086E3-A716-4AD5-BF4D-DC5E18730372Q37418810-8588712B-9B81-4B7A-9A2B-2C3F70C7094DQ37584104-81072067-5C9C-4CA4-9DCE-69C70552591AQ37676603-B2D78B02-A7BB-4EEA-8735-1532E16AE6D0Q37680959-5F626DA0-EB7B-4335-BEE2-2B76F22E5985Q37700237-639835E2-78BA-4CC5-9038-95B91BD82A16Q37907914-9842A8FB-EB6C-4182-8DDB-0B991BF742BDQ38684768-C24E575A-4864-4D9B-AE21-4D882F12B2A4Q39150711-77F18A19-BAE7-42CE-869E-341C5A0F7165Q39156546-0D093EA5-EFFE-4E5A-A553-2854F080ADC0Q39243816-A353A7E2-6500-4859-BDA7-8C2CAD0C96B6Q39686360-3D0D5D2A-6CED-4964-A3D7-BBE63B785309Q40189040-1B417AB8-B8DF-4457-B06E-B3155763484BQ41863015-E4B7794D-42B2-4B24-9EE3-1DC2B2A4585DQ46441995-27362A07-9291-4FFF-BAA4-AD42E62C728EQ47280904-B6C2CC8B-F94A-4787-B2E5-D34703F1FFCBQ47557846-7DF3CFC4-ED1A-4681-8D0D-3A7201E9CF3AQ50675270-B74D8D72-2EFA-472B-B45A-4C9181DFA3F2
P2860
Morphine treatment accelerates sarcoma-induced bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 August 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Morphine treatment accelerates ...... a murine model of bone cancer
@en
Morphine treatment accelerates ...... a murine model of bone cancer.
@nl
type
label
Morphine treatment accelerates ...... a murine model of bone cancer
@en
Morphine treatment accelerates ...... a murine model of bone cancer.
@nl
prefLabel
Morphine treatment accelerates ...... a murine model of bone cancer
@en
Morphine treatment accelerates ...... a murine model of bone cancer.
@nl
P2093
P2860
P1433
P1476
Morphine treatment accelerates ...... a murine model of bone cancer
@en
P2093
Anna Vardanyan
Anne E Cress
Frank Porreca
Josephine Lai
Lisa Majuta
Ohannes Melemedjian
Tamara King
Todd W Vanderah
P2860
P304
P356
10.1016/J.PAIN.2007.06.026
P407
P577
2007-08-15T00:00:00Z